Thermo Fisher Scientific | TMO - Operating Expenses


Thermo Fisher Scientific reported $9.68B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bio Techne USD 243.9M 17.7M Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Henry Schein USD 3.27B 8M Sep/2026
Illumina USD 525M 374M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Laboratory Of America USD 3.39B 117.6M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Olympus JPY 213.3B 2.97B Sep/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.62B 34M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Stryker USD 4.8B 118M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Veracyte USD 133.73M 7.37M Sep/2026
Waters USD 527M 592M Jun/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026